BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23743763)

  • 1. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
    Niyazoglu M; Sayitoglu M; Firtina S; Hatipoglu E; Gazioglu N; Kadioglu P
    Pituitary; 2014 Jun; 17(3):220-6. PubMed ID: 23743763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
    Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
    J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 5. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
    Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
    Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
    Rostomyan L; Daly AF; Petrossians P; Nachev E; Lila AR; Lecoq AL; Lecumberri B; Trivellin G; Salvatori R; Moraitis AG; Holdaway I; Kranenburg-van Klaveren DJ; Chiara Zatelli M; Palacios N; Nozieres C; Zacharin M; Ebeling T; Ojaniemi M; Rozhinskaya L; Verrua E; Jaffrain-Rea ML; Filipponi S; Gusakova D; Pronin V; Bertherat J; Belaya Z; Ilovayskaya I; Sahnoun-Fathallah M; Sievers C; Stalla GK; Castermans E; Caberg JH; Sorkina E; Auriemma RS; Mittal S; Kareva M; Lysy PA; Emy P; De Menis E; Choong CS; Mantovani G; Bours V; De Herder W; Brue T; Barlier A; Neggers SJ; Zacharieva S; Chanson P; Shah NS; Stratakis CA; Naves LA; Beckers A
    Endocr Relat Cancer; 2015 Oct; 22(5):745-57. PubMed ID: 26187128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
    Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
    Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
    Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIP mutation in pituitary adenomas in the 18th century and today.
    Chahal HS; Stals K; Unterländer M; Balding DJ; Thomas MG; Kumar AV; Besser GM; Atkinson AB; Morrison PJ; Howlett TA; Levy MJ; Orme SM; Akker SA; Abel RL; Grossman AB; Burger J; Ellard S; Korbonits M
    N Engl J Med; 2011 Jan; 364(1):43-50. PubMed ID: 21208107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
    Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic features of a large kindred with a germline AIP variant.
    Dal J; Nielsen EH; Klose M; Feldt-Rasmussen U; Andersen M; Vang S; Korbonits M; Jørgensen JOL
    Clin Endocrinol (Oxf); 2020 Aug; 93(2):146-153. PubMed ID: 32324286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
    Ramírez-Rentería C; Hernández-Ramírez LC; Portocarrero-Ortiz L; Vargas G; Melgar V; Espinosa E; Espinosa-de-Los-Monteros AL; Sosa E; González B; Zúñiga S; Unterländer M; Burger J; Stals K; Bussell AM; Ellard S; Dang M; Iacovazzo D; Kapur S; Gabrovska P; Radian S; Roncaroli F; Korbonits M; Mercado M
    Endocrine; 2016 Aug; 53(2):402-11. PubMed ID: 27033541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.
    Urbani C; Russo D; Raggi F; Lombardi M; Sardella C; Scattina I; Lupi I; Manetti L; Tomisti L; Marcocci C; Martino E; Bogazzi F
    J Endocrinol Invest; 2014 Oct; 37(10):949-55. PubMed ID: 24996936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.
    Iwata T; Yamada S; Ito J; Inoshita N; Mizusawa N; Ono S; Yoshimoto K
    Endocr Pathol; 2014 Sep; 25(3):273-81. PubMed ID: 24789813
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
    Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.